Alkermes plc (BOATS:ALKS) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Wendy L Dixon Other companies: Zevra Therapeutics, Inc. (Director · Since at least Apr 25, 2023); Iovance Biotherapeutics, Inc. (Director · Jun 10, 2022 – Jun 10, 2022 · Past); Black Diamond Therapeutics, Inc. (Director · Apr 6, 2022 – Mar 15, 2024 · Past); Arvinas, Inc. (Director · Jun 29, 2020 – Jun 15, 2023 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – Jun 19, 2019 · Past); Voyager Therapeutics, Inc. (Director · Jan 1, 2017 – Jun 4, 2020 · Past); Eleven Biotherapeutics Inc (Director · Oct 22, 2014 – May 19, 2017 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Nov 11, 2021 · Past); Ardea Biosciences Inc (Director · Apr 6, 2011 – Jun 19, 2012 · Past); Furiex Pharmaceuticals Inc (Director · May 27, 2010 – Jul 2, 2014 · Past); Incyte Corporation (Director · May 21, 2010 – Mar 31, 2022 · Past); Orexigen Therapeutics Inc (Director · Apr 20, 2010 – Jun 9, 2015 · Past); Dentsply Sirona Inc. (Director · Jul 31, 2007 – Jul 8, 2010 · Past); Bristol-Myers Squibb Company (CMO & Pres, Global Marketing · Mar 7, 2006 – May 22, 2006 · Past) | Director · Jan 13, 2011 – Jun 14, 2022 · Past |
| Anne Clem Whitaker Other companies: ICON plc (Director · Since at least Mar 18, 2026); OraSure Technologies, Inc. (Director · Nov 8, 2021 – May 15, 2023 · Past); Lisata Therapeutics, Inc. (Director · Nov 1, 2020 – Jan 10, 2022 · Past); Mallinckrodt Inc (Director · May 16, 2018 – Jun 16, 2022 · Past); Bausch Health Companies Inc. (EVP, Company Group Chairman · May 13, 2015 – Dec 5, 2016 · Past); Madrigal Pharmaceuticals, Inc. (President and CEO, Director · Mar 2, 2014 – Sep 3, 2014 · Past); Wolfspeed, Inc. (Director · Dec 2, 2013 – Nov 5, 2020 · Past) | Director · Since at least Sep 14, 2026 |
| Paul Schimmel Other companies: aTyr Pharma, Inc. (Director · Since at least May 6, 2015); Alnylam Pharmaceuticals, Inc. (Co-founder and member of the Board of Directors · Since at least Jan 31, 2006); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – Nov 30, 2007 · Past); Repligen Corporation (Director · Aug 11, 2006 – Jun 14, 2007 · Past) | Director · Mar 2, 2006 – Jun 15, 2007 · Past |
| Frank A. Wilson Other companies: Novanta Inc. (Member of Board of Directors · Since at least May 13, 2021); Cabot Corporation (Director · Since at least Sep 13, 2018); Sparton Corporation (Director · Mar 4, 2019 – Mar 4, 2019 · Past); Revvity, Inc. (Please See Remarks · Dec 7, 2017 – Mar 5, 2018 · Past) | Director · Since at least Sep 12, 2019 |
| James A Robinson Jr Other companies: Eledon Pharmaceuticals, Inc. (Director · Since at least Oct 1, 2023); UroGen Pharma Ltd. (Director · Since at least Jul 25, 2023); Urovant Sciences Ltd (PEO;CEO/Urovant Sciences, Inc., Director · Mar 1, 2019 – Mar 29, 2021 · Past); Neos Therapeutics Inc (Director · Jan 29, 2019 – Mar 19, 2021 · Past) | President & COO,Alkermes, Inc. · Mar 5, 2018 – Apr 4, 2019 · Past |
| Joshua Reed Other companies: Scholar Rock Holding Corporation (Director · Since at least Mar 16, 2021); Omega Therapeutics Inc (Chief Financial Officer · May 23, 2022 – Feb 7, 2024 · Past); Aldeyra Therapeutics, Inc. (Chief Financial Officer · Jul 30, 2018 – Mar 30, 2022 · Past) | SVP, Chief Financial Officer · Since at least Sep 12, 2025 |
| Nancy L. Snyderman Other companies: Lyra Therapeutics, Inc. (Board Director · Since at least Oct 27, 2020); Future Health Esg Corp (Director · Sep 9, 2021 – Oct 24, 2021 · Past); Axonics Modulation Technologies Inc (Director · Apr 8, 2019 – Aug 24, 2020 · Past) | Director · Since at least May 23, 2018 |
| Nancy S. Lurker Other companies: Collegium Pharmaceutical, Inc. (Director · Since at least Feb 4, 2025); EyePoint, Inc. (Director · Since at least Mar 29, 2019); Aquestive Therapeutics, Inc. (Director · Jun 13, 2019 – Jun 15, 2021 · Past) | Director · Since at least Mar 5, 2024 |
| Richard F. Pops Other companies: Neurocrine Biosciences, Inc. (Director · Since at least May 28, 2015); Acceleron Pharma Inc (Director · Mar 3, 2016 – Jan 25, 2019 · Past); Epizyme Inc (Director · Jul 8, 2015 – May 29, 2020 · Past) | Director · Since at least Sep 10, 2015 |
| James M. Frates Other companies: Amylyx Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Jan 6, 2022); Sage Therapeutics Inc (Director · Since at least Jul 17, 2014) | SVP, Alks Inc; CFO ALKS · May 2, 2006 – May 14, 2020 · Past |
| Shane M. Cooke Other companies: Prothena Corporation plc (Director · Since at least May 16, 2018); Endo International PLC (Director · Jun 8, 2018 – Jun 11, 2021 · Past) | Director · Since at least Jan 11, 2018 |
| Brian P. McKeon Other companies: Dentsply Sirona Inc. (Director · Since at least Feb 24, 2026) | Director · Since at least Aug 18, 2025 |
| Craig Hopkinson Other companies: Albireo Pharma Inc (Director · Dec 1, 2022 – Mar 2, 2023 · Past) | Executive Vice President, Research & Development and Chief Medical Officer · Since at least Jun 7, 2019 |
| Emily Peterson Alva Other companies: Amneal Pharmaceuticals, Inc. (Director · May 4, 2018 – May 5, 2025 · Past) | Director · May 18, 2021 – Jun 29, 2024 · Past |
| Michael J Landine Other companies: Kopin Corporation (Director · May 11, 2012 – May 9, 2018 · Past) | SVP, Corp Dev., Alkermes, Inc. · Oct 3, 2011 – Feb 23, 2024 · Past |
| Richard B. Gaynor Other companies: Zai Lab Ltd. (Director · Since at least Nov 19, 2021) | Director · Since at least Dec 2, 2020 |
| Andy Wilson | Director · Since at least Feb 25, 2026 |
| Anne C. Whitaker | Director · Since at least Sep 16, 2026 |
| Anne Giovanoni | Senior Vice President, Corporate Counsel and Secretary · Since at least Nov 5, 2026 |
| Bhaskar Rege | Senior Vice President, Discovery Medicine & Pharmaceutical Sciences · Since at least Nov 5, 2026 |
| Blair Jackson | Chief Executive Officer · Since at least Jan 11, 2021 |
| Cato T. Laurencin | Director · Since at least May 21, 2026 |
| Christopher I. Wright M.D. | Director · Since at least May 21, 2026 |
| David Angelo Daglio Jr | Director · Dec 9, 2020 – Jun 29, 2024 · Past |
| David Gaffin | EVP, CLO, Alkermes, Inc. · Since at least Feb 16, 2021 |
| Declan O’Connor | Senior Vice President, Operations and Environment, Health and Safety (EHS) · Since at least Nov 5, 2026 |
| Drew Sansone | Senior Vice President, Regulatory Affairs · Since at least Nov 5, 2026 |
| Elliot Ehrich | EVP, R&D & CMO, Alkermes, Inc. · May 17, 2010 – May 28, 2017 · Past |
| Gordon G Pugh | SVP, COO & CRO, Alkermes, Inc. · Sep 21, 2006 – Dec 31, 2016 · Past |
| James Schoener | Senior Vice President, Business Development and Alliance Management · Since at least Nov 5, 2026 |
| Jamie Constantine | Investor Relations · Since at least Jul 14, 2026 |
| Julie Lekstrom Himes | Senior Vice President, Clinical Development · Since at least Oct 13, 2026 |
| Kanchan Relwani | Senior Vice President, Medical Affairs · Since at least Apr 30, 2025 |
| Paul J Mitchell | Director · Sep 21, 2006 – May 20, 2021 · Past |
| Peter Norman | Senior Vice President, Policy, Government & Community Relations · Since at least Nov 5, 2026 |
| Robert A Breyer | Director · Oct 5, 2011 – May 20, 2021 · Past |
| Samuel Joseph Parisi | VP, Finance (Interim PAO) · Since at least May 29, 2026 |
| Sandy Coombs | Investor Relations · Since at least Apr 21, 2026 |
| Stephen Schiavo | Senior Vice President, Chief Human Resources Officer · Since at least Nov 5, 2026 |
| Todd Nichols | Senior Vice President, Chief Commercial Officer · Since at least Nov 5, 2026 |
| Tom Skoff | Senior Vice President, Chief Information Officer · Since at least Nov 5, 2026 |